News & Analysis as of

Hatch-Waxman Pharmaceutical Patents Drug Approvals

Robins Kaplan LLP

ANDA Approvals

Robins Kaplan LLP on

New Drug Applications and 505(B)(2) Applications - This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA....more

American Conference Institute (ACI)

[Virtual Event] FDA Boot Camp - September 23rd - 24th, 8:15 am - 12:45 pm EDT

For over 15 years, ACI’s FDA Boot Camp has been the Training Grounds for Life Sciences Attorneys and Executives to Master the Fundamentals of FDA Regulation. Now the conference returns for its 37th iteration, in a fully...more

Robins Kaplan LLP

ANDA Approvals - Winter 2018

Robins Kaplan LLP on

Please see Chart below for more information....more

Robins Kaplan LLP

Generic Launches - Fall 2018

Robins Kaplan LLP on

Please see Chart below for more information. ...more

Smart & Biggar

Rx IP Update - November 2017

Smart & Biggar on

Canada’s new linkage litigation scheme: A comparison to Hatch-Waxman - The September 21, 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations (see our article here) introduced a new scheme for...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide